Administration of exogenous haptoglobin improves survival in a canine model of sepsis [50], and there is some retrospective data suggesting that exogenous haptoglobin administration reduces acute kidney injury (AKI) in humans undergoing cardiac surgery [51]. The gene discussed is HP; the disease is Sepsis.